Literature DB >> 34086348

The ever-increasing importance of cancer as a leading cause of premature death worldwide.

Freddie Bray1, Mathieu Laversanne1, Elisabete Weiderpass1, Isabelle Soerjomataram1.   

Abstract

The relative importance of cardiovascular disease (CVD) and cancer as leading causes of premature death are examined in this communication. CVD and cancer are now the leading causes in 127 countries, with CVD leading in 70 countries (including Brazil and India) and cancer leading in 57 countries (including China). Such observations can be seen as part of a late phase of an epidemiologic transition, taking place in the second half of the 20th century and the first half of the present one, in which the dominance of infectious diseases is progressively superseded by noncommunicable diseases. According to present ranks and recent trends, cancer may surpass CVD as the leading cause of premature death in most countries over the course of this century. Clearly, governments must factor in these transitions in developing cancer policies for the local disease profile.
© 2021 American Cancer Society.

Entities:  

Keywords:  cancer control; cardiovascular disease (CVD); epidemiologic transition; noncommunicable diseases (NCDs); premature mortality

Mesh:

Year:  2021        PMID: 34086348     DOI: 10.1002/cncr.33587

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  126 in total

1.  Polarization-based probabilistic discriminative model for quantitative characterization of cancer cells.

Authors:  Jiachen Wan; Yang Dong; Jing-Hao Xue; Liyan Lin; Shan Du; Jia Dong; Yue Yao; Chao Li; Hui Ma
Journal:  Biomed Opt Express       Date:  2022-05-11       Impact factor: 3.562

2.  Serine O-acetyltransferase derived NV14 peptide reduces cytotoxicity in H2O2 induced MDCK cells and inhibits MCF-7 cell proliferation through caspase gene expression.

Authors:  Manikandan Velayutham; B Haridevamuthu; P Snega Priya; Munuswamy Ramanujam Ganesh; Annie Juliet; Jesu Arockiaraj
Journal:  Mol Biol Rep       Date:  2022-08-08       Impact factor: 2.742

Review 3.  The role of nutrition in harnessing the immune system: a potential approach to prevent cancer.

Authors:  Hu Xiaogang; Monika Sharma; Irfan Saif; Gohar Ali; Xiangkai Li; El-Sayed Salama
Journal:  Med Oncol       Date:  2022-09-30       Impact factor: 3.738

Review 4.  Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.

Authors:  Qing Wu; Wei Qian; Xiaoli Sun; Shaojie Jiang
Journal:  J Hematol Oncol       Date:  2022-10-08       Impact factor: 23.168

Review 5.  Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets.

Authors:  Rui Qin; Feng-Ming You; Qian Zhao; Xin Xie; Cheng Peng; Gu Zhan; Bo Han
Journal:  J Hematol Oncol       Date:  2022-09-14       Impact factor: 23.168

Review 6.  Targeting the (pro)renin receptor in cancers: from signaling to pathophysiological effects.

Authors:  Xin Ouyang; Chuanming Xu
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-25       Impact factor: 4.322

7.  Trends of cancer mortality in Xi'an City, China: 2005-2020.

Authors:  Ning Chen; Xiao-Yu Zhang; Lin-Lin Ma; Guo-Dong Zhao; Yu-Xiang Yan
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-14       Impact factor: 4.322

8.  HBV preS Mutations Promote Hepatocarcinogenesis by Inducing Endoplasmic Reticulum Stress and Upregulating Inflammatory Signaling.

Authors:  Wenbin Liu; Shiliang Cai; Rui Pu; Zixiong Li; Donghong Liu; Xinyu Zhou; Jianhua Yin; Xi Chen; Liping Chen; Jianfeng Wu; Xiaojie Tan; Xin Wang; Guangwen Cao
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

9.  Dosimetric and radiobiological comparison in head-and-neck radiotherapy using JO-IMRT and 3D-CRT.

Authors:  Duong Thanh Tai; Luong Thi Oanh; Pham Hoai Phuong; Abdelmoneim Sulieman; Fouad A Abolaban; Hiba Omer; James C L Chow
Journal:  Saudi J Biol Sci       Date:  2022-06-02       Impact factor: 4.052

Review 10.  Advances in Clinical Oncology Research on 99mTc-3PRGD2 SPECT Imaging.

Authors:  Liming Xiao; Jun Xin
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.